ArticleCancer research2022

Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy.

Alvaro Quintanal-Villalonga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.